About the Company
axcella has pioneered a new therapeutic class – defined amino acid compositions (daacs™). our daac therapeutics leverage the essential signaling function of amino acids to restore health across a network of dysregulated pathways, and provide safer solutions for patients with complex disease. with our axcellerator™ platform, we are transforming traditional drug discovery and development by generating patient data in less than a year from indication selection. this platform has delivered a rich pipeline including clinical programs in liver, metabolic, cns and orphan diseases.
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology
Employees
58
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $AXLA News
Axcella Health Inc. (AXLA)
*The upcoming earnings date is derived from an algorithm based on a company's historical reporting dates. It is possible that this date will be updated in the future, once the company announces ...
Axcella Health
© 2024 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and ...
Stoke Therapeutics CFO Stephen Tulipano Resigns; Thomas Leggett Named Replacement
Stoke Therapeutics, Inc. (STOK) on Monday said its Chief Financial Officer Stephen Tulipano is stepping down with effect from May 7.
Nestle Health Science US Holdings, Inc.'s Net Worth
This is based on reported shares across multiple companies, which include Seres Therapeutics, Inc., Axcella Health Inc., and Aimmune Therapeutics, Inc.. Attention insiders: Dive deeper into market ...
Complete Coverage
CHICAGO -- One of the first trials aimed at tackling long COVID helped some patients recover from lingering physical and mental fatigue, although the drug developed by Axcella Health Inc failed on ...
NIMCO US, Inc.'s Net Worth
This is based on reported shares across multiple companies, which include Seres Therapeutics, Inc., Axcella Health Inc., and Aimmune Therapeutics, Inc.. Attention insiders: Dive deeper into market ...
Axcella antes up in key liver diseases with EMM (endogenous metabolic modulator) compositions
to treat complex diseases and restore health. One such disease, nonalcoholic steatohepatitis (NASH), is characterized by dysregulated metabolism, inflammation and fibrosis. According to Axcella ...
Guardant Health Inc.
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
EVH Evolent Health, Inc.
Evolent Health, Inc., through its subsidiary, Evolent Health LLC, offers specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company ...
Cardinal Health Inc CAH
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Axcella Health Inc. Common Stock (AXLA)
Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary and as a result, these ...
Loading the latest forecasts...